Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (1877)	1/24/2002 2:10:27 AM
From: Miljenko Zuanic	Read Replies (3) of 2515

<<"What is the chances that if IMCL goes back and does the required protocol for testing that they might loss the patent on the drug.">> How can future trails protocol change validity of the issued patent? Patent can only be re-examined if claims are supported with false (or fabricated) results. Regards the fraud, did you ask BTRN management why they were selling share at open market while proposing secondary (which may be at deep discount). Whose interest they were protecting, and working for? Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next